SCHEMBL6124157

SCHEMBL6124157

CC1C(C)C12CCCc1cc(F)ccc12

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 6/20 0.46
SRD5A1 P18405 1/20 0.41
CYP17A1 P05093 2/20 0.39
CYP3A4 P08684 2/20 0.39
CYP11B2 P19099 2/20 0.39
CYP11B1 P15538 1/20 0.39
HTR2A P28223 1/20 0.37
HTR2C P28335 1/20 0.37
ACHE P22303 1/20 0.36
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
TRPA1 O75762 1/20 0.33
NOTUM Q6P988 1/20 0.33
HDAC4 P56524 1/20 0.33
HTR1D P28221 1/20 0.33
HTR1B P28222 1/20 0.33
NPC1 O15118 1/20 0.33
ALDH1A1 P00352 1/20 0.33
HTT P42858 1/20 0.33
RAB9A P51151 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6124156 0.90 KDM1A (0.44) KDM1ASRD5A1CYP17A1CYP3A4CYP11B2
SCHEMBL24538626 0.75 KDM1A (0.44) KDM1ASRD5A1CYP17A1CYP3A4CYP11B2
Hydrochloric Acid SCHEMBL9715536 0.71 KDM1A (0.41) KDM1ASRD5A1CYP17A1CYP3A4CYP11B2
SCHEMBL17931722 0.71 KDM1A (0.41) KDM1ASRD5A1CYP17A1CYP3A4CYP11B2
SCHEMBL20738977 0.71 KDM1A (0.41) KDM1ASRD5A1CYP17A1CYP3A4CYP11B2
SCHEMBL16501543 0.69 SRD5A1 (0.46) KDM1ASRD5A1CYP17A1CYP3A4CYP11B2
SCHEMBL12234883 0.69 AKR1B1 (0.41)
SCHEMBL19126994 0.68 KDM1A (0.36) KDM1ASRD5A1CYP17A1CYP3A4CYP11B2
SCHEMBL12188662 0.68 KDM1A (0.56) KDM1ASRD5A1CYP17A1CYP3A4CYP11B2
SCHEMBL27305458 0.68 HTR1D (0.43) KDM1ASRD5A1HTR2AHTR2CACHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8487099-B2 Gamma secretase modulators MERCK SHARP & DOHME CORP. (US) 2013-07-16 US disclosed
US-20120107328-A1 GAMMA SECRETASE MODULATORS MERCK SHARP & DOHME CORP. 2012-05-03 US disclosed
US-20110263529-A1 GAMMA SECRETASE MODULATORS MERCK SHARP & DOHME CORP. 2011-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120107328-A1 GAMMA SECRETASE MODULATORS BACE1, BACE2, PSEN1 KDM1A 3235/4885SRD5A1 2162/4885CYP17A1 624/4885
US-20110263529-A1 GAMMA SECRETASE MODULATORS BACE1, BACE2, PSEN1 KDM1A 2758/4885SRD5A1 3715/4885CYP17A1 2596/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.